A pharmacological review of raloxifene
- 1 March 1996
- journal article
- review article
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 14 (1) , 1-9
- https://doi.org/10.1007/bf01771666
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Raloxifene: A selective estrogen receptor modulatorJournal of Bone and Mineral Metabolism, 1994
- Postmenopausal Estrogen Therapy and Cardiovascular DiseaseNew England Journal of Medicine, 1991
- Interactions between Estrogens, Androgens, Progestins, and Glucocorticoids in ZR‐75‐1 Human Breast Cancer CellsAnnals of the New York Academy of Sciences, 1990
- Actions of oestrogens and antioestrogens on rat mammary gland development: Relevance to breast cancer preventionJournal of Steroid Biochemistry, 1988
- Glucocorticoids stimulate the growth of mouse mammary carcinoma Shionogi cells in cultureMolecular and Cellular Endocrinology, 1988
- Phase II Evaluation of Lyl56758 in Metastatic Breast CancerOncology, 1988
- Non-steroidal antioestrogens—Receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cellsJournal of Steroid Biochemistry, 1984
- Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogensJournal of Endocrinology, 1983
- Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levelsLife Sciences, 1983
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976